| 产品编号 |
产品名称 |
序列 |
别称 |
CAS Number |
分子式 |
分子量 |
疾病类 |
包装 |
| 4459-v |
Neuropeptide B-29 (Rat) (Non-Brominated Form)
|
序列
|
|
434897-73-1 |
|
|
|
|
| Trp-Tyr-Lys-Pro-Ala-Ala-Gly-Ser-His-His-Tyr-Ser-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Ser-Phe-His-Arg-Phe-Pro-Ser-Thr |
| 4461-v |
RFamide-Related Peptide-3 (Human)
|
序列
|
|
311309-27-0 |
|
|
|
|
| Val-Pro-Asn-Leu-Pro-Gln-Arg-Phe-NH2 |
| 4462-v |
RFamide-Related Peptide-3 (Rat)
|
序列
|
|
420088-80-8 |
|
|
|
|
| Ala-Asn-Met-Glu-Ala-Gly-Thr-Met-Ser-His-Phe-Pro-Ser-Leu-Pro-Gln-Arg-Phe-NH2 |
| 4464-v |
[D-Leu7]-(-)-Ternatin
|
序列
|
|
1005766-32-4 |
|
|
|
|
| cyclo(-D-aIle-MeAla-MeLeu-Leu-MeAla-D-MeAla-D-Leu-) |
| 4467-v |
Hepcidin (Rat)
|
序列
|
|
|
|
|
|
|
| Asp-Thr-Asn-Phe-Pro-Ile-Cys-Leu-Phe-Cys-Cys-Lys-Cys-Cys-Lys-Asn-Ser-Ser-Cys-Gly-Leu-Cys-Cys-Ile-Thr (Disulfide bonds undetermined) |
| 4468-s |
AMP-IBP5 (Human)
|
序列
|
|
1275621-23-2 |
|
|
|
|
| Ala-Val-Tyr-Leu-Pro-Asn-Cys-Asp-Arg-Lys-Gly-Phe-Tyr-Lys-Arg-Lys-Gln-Cys-Lys-Pro-Ser-Arg-NH2 (Disulfide bond between Cys7-Cys18) |
| 4470-v |
Catestatin (Human)
|
序列
|
|
197151-46-5 |
|
|
|
|
| Ser-Ser-Met-Lys-Leu-Ser-Phe-Arg-Ala-Arg-Ala-Tyr-Gly-Phe-Arg-Gly-Pro-Gly-Pro-Gln-Leu |
| 4472-s |
APETx2
|
序列
|
|
713544-47-9 |
|
|
|
|
| Gly-Thr-Ala-Cys-Ser-Cys-Gly-Asn-Ser-Lys-Gly-Ile-Tyr-Trp-Phe-Tyr-Arg-Pro-Ser-Cys-Pro-Thr-Asp-Arg-Gly-Tyr-Thr-Gly-Ser-Cys-Arg-Tyr-Phe-Leu-Gly-Thr-Cys-Cys-Thr-Pro-Ala-Asp (Reported disulfide bonds between Cys4-Cys37, Cys6-Cys30, Cys20-Cys38) |
| 4473-s |
Mambalgin-1
|
序列
|
|
1401381-87-0 |
|
|
|
|
| Leu-Lys-Cys-Tyr-Gln-His-Gly-Lys-Val-Val-Thr-Cys-His-Arg-Asp-Met-Lys-Phe-Cys-Tyr-His-Asn-Thr-Gly-Met-Pro-Phe-Arg-Asn-Leu-Lys-Leu-Ile-Leu-Gln-Gly-Cys-Ser-Ser-Ser-Cys-Ser-Glu-Thr-Glu-Asn-Asn-Lys-Cys-Cys-Ser-Thr-Asp-Arg-Cys-Asn-Lys (Predicted disulfide bonds between Cys3-Cys19, Cys12-Cys37, Cys41-Cys49, and Cys50-Cys55) |
| 4474-v |
Angiotensin A
|
序列
|
|
51833-76-2 |
|
|
|
|
| Ala-Arg-Val-Tyr-Ile-His-Pro-Phe |
| 4475-v |
Alamandine
|
序列
|
|
1176306-10-7 |
|
|
|
|
| Ala-Arg-Val-Tyr-Ile-His-Pro |
| 4476-v |
[Sar1, Ile4,8]-Angiotensin II
|
序列
|
|
185461-45-4 |
|
|
|
|
| Sar-Arg-Val-Ile-Ile-His-Pro-Ile |
| 4477-s |
Phytosulfokine
|
序列
|
|
179667-62-0 |
|
|
|
|
| Tyr(SO3H)-Ile-Tyr(SO3H)-Thr-Gln |
| 4479-s |
TIP39
|
序列
|
|
277302-47-3 |
|
|
|
|
| Ser-Leu-Ala-Leu-Ala-Asp-Asp-Ala-Ala-Phe-Arg-Glu-Arg-Ala-Arg-Leu-Leu-Ala-Ala-Leu-Glu-Arg-Arg-His-Trp-Leu-Asn-Ser-Tyr-Met-His-Lys-Leu-Leu-Val-Leu-Asp-Ala-Pro |
| 4481-v |
Amyloid β-Protein (Human, 1-28)
|
序列
|
|
109770-29-8 |
|
|
|
|
| Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys |
| 4482-s |
Orexin-A (Human, 17-33)
|
序列
|
|
343268-91-7 |
|
|
|
|
| Tyr-Glu-Leu-Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Leu-NH2 |
| 4483-s |
[Ala11, D-Leu15]-Orexin B (Human)
|
序列
|
|
532932-99-3 |
|
|
|
|
| Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Ala-Gln-Arg-Leu-D-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 |
| 4484-v |
Amyloid β-Protein (Human, 1-38)
|
序列
|
|
131438-74-9 |
|
|
|
|
| Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly |
| 4485-v |
p3-Alcβ37
|
序列
|
|
1401650-06-6 |
|
|
|
|
| Val-Leu-Ser-Ser-Gln-Gln-Phe-Leu-His-Arg-Gly-His-Gln-Pro-Pro-Pro-Glu-Met-Ala-Gly-His-Ser-Leu-Ala-Ser-Ser-His-Arg-Asn-Ser-Met-Ile-Pro-Ser-Ala-Ala-Thr |
| 4486-v |
[Ser(PO3H2)65]-Ubiquitin
|
序列
|
|
|
|
|
|
|
| Met-Gln-Ile-Phe-Val-Lys-Thr-Leu-Thr-Gly-Lys-Thr-Ile-Thr-Leu-Glu-Val-Glu-Pro-Ser-Asp-Thr-Ile-Glu-Asn-Val-Lys-Ala-Lys-Ile-Gln-Asp-Lys-Glu-Gly-Ile-Pro-Pro-Asp-Gln-Gln-Arg-Leu-Ile-Phe-Ala-Gly-Lys-Gln-Leu-Glu-Asp-Gly-Arg-Thr-Leu-Ser-Asp-Tyr-Asn-Ile-Gln-Lys-Glu-Ser(PO3H2)-Thr-Leu-His-Leu-Val-Leu-Arg-Leu-Arg-Gly-Gly |
沪公网安备 31011502005552号
沪ICP备13005633号-1